Securities lawyers at Goldfarb LLP are investigating alleged violations of shareholder protection laws by officers and directors of Coventry Health Care, Inc. (NYSE: CVH) in connection with a buyout for $42.08 per share to Aetna. Concerned CVH investors are encouraged to contact attorney Hamilton Lindley at 877-583-2855 or email@example.com about their rights and remedies. “Our potential lawsuit will ascertain whether the company has been adequately and fairly shopped,” said Hamilton Lindley. “We’ll seek to ensure that all relevant information is disclosed so that shareholder interests are protected in terms of price and information.” Goldfarb LLP lawyers have significant experience representing shareholders and whistleblowers in securities lawsuits nationwide. RBN stockholders – or anyone with knowledge about this acquisition – should contact lawyer Hamilton Lindley at firstname.lastname@example.org or 877-583-2855 with questions or concerns.
Coventry Health Care (NYSE:CVH) hit a new 52-week high Monday as it is currently trading at $50.34, above its previous 52-week high of $50.24 with 62,304 shares traded as of 10:06 a.m. ET. Average volume has been one million shares over the past 30 days.
Coventry Health Care (NYSE:CVH) hit a new 52-week high Thursday as it is currently trading at $49.42, above its previous 52-week high of $49.40 with 7,164 shares traded as of 9:31 a.m. ET. Average volume has been 1.1 million shares over the past 30 days.